Schedule 13D ownership disclosure
Vir Biotechnology Inc
Security class unavailable · CUSIP: 92764N102
Event date: 2021-12-20
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 14.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-22-000412
- Form type
- SC 13D
- Filer
- ARCH Venture Fund IX, L.P.
- CIK
- CIK 1666306
- Filed
- May 10, 2022
- Reporting period
- Dec 20, 2021
- Description
- Schedule 13D beneficial ownership